8-KThe DealStrategic
Acquisition / Disposition · Shareholder Vote
Filed Nov 10, 2022 · 3y ago · Accession 0001193125-22-282630
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K
- Filing date
- Nov 10, 2022
- Report date
- Nov 9, 2022
- Document
- d752591d8k.htm
- Size
- 193 KB